Insights

Innovative Market Position VeriSIM Life is positioned as a technological leader in AI-driven biosimulation for drug development, which presents an opportunity to target pharmaceutical companies seeking cutting-edge solutions to accelerate drug pipelines and improve success rates.

Recent Industry Recognition With multiple awards and nominations such as the 2025 AI Breakthrough Award and recognition at Reuters Pharma Awards, the company has heightened credibility and visibility, making it a compelling partner for strategic collaborations and investors.

Growing Financial Base Having secured $15 million in funding and generating up to $10 million in revenue, VeriSIM is in a growth phase that offers potential for upselling additional AI solutions or expanding into new pharmaceutical research segments.

Expansion Opportunities The company's focus on AI biosimulation models presents opportunities to expand partnerships with mid-sized to large pharma firms looking to replace or augment traditional animal testing methods with more ethical and efficient AI-based alternatives.

Technological Edge VeriSIM's use of advanced AI and machine learning platforms provides a strong foundation for developing tailored solutions, which could be valuable for organizations seeking bespoke digital transformation tools in biotech R&D.

VeriSIM Life Tech Stack

VeriSIM Life uses 8 technology products and services including Hotjar, AdRoll CMP System, Open Graph, and more. Explore VeriSIM Life's tech stack below.

  • Hotjar
    Analytics
  • AdRoll CMP System
    Consent Management
  • Open Graph
    Content Management System
  • Google Sheets
    Office Suites
  • Webflow
    Page Builders
  • reCAPTCHA
    Security
  • HSTS
    Security
  • Facebook
    Widgets

Media & News

VeriSIM Life's Email Address Formats

VeriSIM Life uses at least 1 format(s):
VeriSIM Life Email FormatsExamplePercentage
First.Last@verisimlife.comJohn.Doe@verisimlife.com
49%
FiLast@verisimlife.comJoDoe@verisimlife.com
1%
First.Last@verisimlife.comJohn.Doe@verisimlife.com
49%
FiLast@verisimlife.comJoDoe@verisimlife.com
1%

Frequently Asked Questions

What is VeriSIM Life's official website and social media links?

Minus sign iconPlus sign icon
VeriSIM Life's official website is verisimlife.com and has social profiles on LinkedInCrunchbase.

What is VeriSIM Life's SIC code NAICS code?

Minus sign iconPlus sign icon
VeriSIM Life's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does VeriSIM Life have currently?

Minus sign iconPlus sign icon
As of December 2025, VeriSIM Life has approximately 20 employees across 2 continents, including North AmericaEurope. Key team members include Head Of Biosimulations: D. B.Executive Assistant To Ceo: B. W.Senior Computational Chemist: A. T.. Explore VeriSIM Life's employee directory with LeadIQ.

What industry does VeriSIM Life belong to?

Minus sign iconPlus sign icon
VeriSIM Life operates in the Biotechnology Research industry.

What technology does VeriSIM Life use?

Minus sign iconPlus sign icon
VeriSIM Life's tech stack includes HotjarAdRoll CMP SystemOpen GraphGoogle SheetsWebflowreCAPTCHAHSTSFacebook.

What is VeriSIM Life's email format?

Minus sign iconPlus sign icon
VeriSIM Life's email format typically follows the pattern of First.Last@verisimlife.com. Find more VeriSIM Life email formats with LeadIQ.

How much funding has VeriSIM Life raised to date?

Minus sign iconPlus sign icon
As of December 2025, VeriSIM Life has raised $15M in funding. The last funding round occurred on Jan 13, 2022 for $15M.

When was VeriSIM Life founded?

Minus sign iconPlus sign icon
VeriSIM Life was founded in 2017.

VeriSIM Life

Biotechnology ResearchCalifornia, United States11-50 Employees

VeriSIM Life is building AI enabled biosimulation models. 
VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. 

VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $15M

    VeriSIM Life has raised a total of $15M of funding over 4 rounds. Their latest funding round was raised on Jan 13, 2022 in the amount of $15M.

  • $1M$10M

    VeriSIM Life's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $15M

    VeriSIM Life has raised a total of $15M of funding over 4 rounds. Their latest funding round was raised on Jan 13, 2022 in the amount of $15M.

  • $1M$10M

    VeriSIM Life's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.